Genfit S.A. (NASDAQ:GNFT – Free Report) – Research analysts at Leerink Partnrs issued their FY2026 earnings per share (EPS) estimates for Genfit in a report issued on Monday, February 5th. Leerink Partnrs analyst T. Smith anticipates that the company will post earnings per share of ($0.67) for the year. The consensus estimate for Genfit’s current […]
Related Keywords
Leerink Partnrs , Shaughnessy Asset Management , Citadel Advisors , Envestnet Asset Management Inc , Optiver Holding , Genfit Company Profile , Free Report , Asset Management , Get Free Report , Urea Cycle Disorder , Organic Acidemia Disorder , Genfit Daily , Genfit , Nasdaq Gnft , Gnft , Medical , Earnings Estimates ,
vimarsana.com © 2020. All Rights Reserved.